Randomized, controlled research conducted in an Indonesian city confirms the reduction in cases seen with previous observational work.

The recent news of consumers hoarding gasoline in the face of a brief closure of one of the world’s biggest petroleum pipelines is just the latest episode of panic buying since the COVID-19 pandemic started.

Meet some of the people featured in the June 2021 issue of The Scientist.

In addition to continued scruitiny of the SARS-CoV-2 virus, research on similar pathogens could aid in the fight against the COVID-19 pandemic and future disease outbreaks.

Transplanted CAR stem cells persisted long term and showed multilineage engraftment in tissues that harbor HIV.

Learn to optimize ELISA experiments in this workshop.

Doctors are reporting an uptick in cases of a highly lethal condition called mucormycosis that might be linked to steroid treatments for SARS-CoV-2.

Discover new RNA extraction and purification strategies and how they enable reliable and sensitive viral detection.

The Centenary University professor studies the far-reaching effects of changes in the gut bacteria of mosquitos and other species.

Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso.

After a handful of cases in Ireland, clinicians there are warning that the virus might infect the placenta in very rare instances and cause fetal distress, but a rise in stillbirths has not been seen in epidemiological studies.

It’s unclear how long protections against infection will last from the initial vaccinations, and health authorities say additional jabs will likely be necessary.

Researchers involved in a long-term project to identify viruses of concern have now assessed the risk factors that could help forecast which pathogens are the most likely to spillover from wildlife to people.

From a loss of taste to dementia, infectious agents cause an array of neurological symptoms.

A review of hundreds of cases finds that only a minority of patients noted being sick with a coronavirus infection prior to developing the severe inflammatory condition.

Researchers identify signatures that predict how a person will respond to an immune system stimulus.

Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.

Identifying molecular targets for SARS-CoV-2 therapeutics.

Aedes scapularis is already established on the peninsula, and researchers predict that its population will continue to spread.